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Abstract
A general paucity of knowledge about the metabolic state of Mycobacterium tuberculosis within the host environment is a
major factor impeding development of novel drugs against tuberculosis. Current experimental methods do not allow direct
determination of the global metabolic state of a bacterial pathogen in vivo, but the transcriptional activity of all encoded
genes has been investigated in numerous microarray studies. We describe a novel algorithm, Differential Producibility
Analysis (DPA) that uses a metabolic network to extract metabolic signals from transcriptome data. The method utilizes Flux
Balance Analysis (FBA) to identify the set of genes that affect the ability to produce each metabolite in the network.
Subsequently, Rank Product Analysis is used to identify those metabolites predicted to be most affected by a transcriptional
signal. We first apply DPA to investigate the metabolic response of E. coli to both anaerobic growth and inactivation of the
FNR global regulator. DPA successfully extracts metabolic signals that correspond to experimental data and provides novel
metabolic insights. We next apply DPA to investigate the metabolic response of M. tuberculosis to the macrophage
environment, human sputum and a range of in vitro environmental perturbations. The analysis revealed a previously
unrecognized feature of the response of M. tuberculosis to the macrophage environment: a down-regulation of genes
influencing metabolites in central metabolism and concomitant up-regulation of genes that influence synthesis of cell wall
components and virulence factors. DPA suggests that a significant feature of the response of the tubercle bacillus to the
intracellular environment is a channeling of resources towards remodeling of its cell envelope, possibly in preparation for
attack by host defenses. DPA may be used to unravel the mechanisms of virulence and persistence of M. tuberculosis and
other pathogens and may have general application for extracting metabolic signals from other ‘‘-omics’’ data.
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Introduction
The M. tuberculosis complex includes the human pathogen M.
tuberculosis, the bovine tubercle bacillus, M. bovis and the attenuated
vaccine strain derived from M. bovis. Tuberculosis (TB) causes 2–3
million deaths each year [1] [2]. Outbreaks of TB due to
multidrug-resistant (MDR) and extensively drug-resistant (XDR)
strains have become increasingly common in many parts of the
world [3]. Control of TB is compromised by the fact that
successful treatment takes 6 months or more, leading to lack of
patient compliance and subsequent emergence of drug-resistance.
These lengthy drug treatment regimes are necessary to kill slowly
growing or non-growing cells, known as persisters, in lesions that
are refractory to drug treatment [4]. Development of new drugs
able to efficiently kill persistent cells could lead to shorter
treatment regimes and more effective control of TB. However,
very little is known about the physiological and metabolic state of
the TB bacillus in vivo. The glyoxylate shunt appears to be required
during intracellular growth indicating that M. tuberculosis survives
by scavenging host lipids [5–6] [7]; and recent evidence indicates
that host cholesterol may be carbon source utilized in vivo [8,9].
Gluconeogenesis has also been shown to be required for growth in
vivo [10]. There is also growing evidence of a shift to anaerobic
respiration during dormant/latent/persistent infection [11] [12]
[13]. These findings have been useful in directing rational drug
development [14] but a more complete understanding of M.
tuberculosis metabolism in vivo remains a major goal of TB drug
research.
There are many approaches to studying the physiology of
bacterial cells in vitro. High throughput methods such as
metabolomics, proteomics and transcriptomics may be combined
with traditional biochemical, physiological and structural investi-
gations to define the physiological state of the organism in vitro.
These data may be incorporated into genome-scale models of
bacterial cells to build virtual cells capable of simulating the
growth of bacteria [15] [16] [17] both in vitro and in vivo. Recently,
two genome-scale models of the TB bacillus have been published
[18] [19] allowing this approach to be applied to modeling the
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whereas it is relatively straightforward to obtain multiple
measurements for bacteria to define a physiological or metabolic
state in vitro, only limited information can be obtained for in vivo.I n
particular, it is very challenging to perform metabolomic,
proteomic, biochemical, physiological or structural studies with
the small numbers of organisms obtained from infected tissue.
However, it is possible to perform transcriptome studies on in vivo
grown organisms and these methods have been applied to the TB
bacillus to obtain transcriptome profiles of bacteria growing in
cultured macrophages, mouse models and in human lesions
[20,21] [22] [23] [24]. The transcriptional profile of a cell can
define most aspects of its physiological state; therefore it should be
possible to predict a physiological state from knowledge of its
complete transcriptome. However the mapping between messen-
ger RNA levels and physiological state is highly complex and non-
linear depending on many unknown factors such as mRNA
stability, translation efficiency and post-translational modification
of proteins. Traditional approaches to defining metabolic
responses from transcriptome data have generally relied on
examining expression levels of key (rate-controlling) genes in
metabolic pathways (for instance, [25]. However, metabolic
control analysis has demonstrated that control is distributed
throughout the entire metabolic network, such that the flux
through any particular pathway is controlled globally [26,27]
rather than by a particular enzymatic step. This makes a simple
mapping of differentially expressed genes onto metabolic pathways
an unrealistic strategy for successful predictions of global metabolic
state changes.
Several system-level approaches have been proposed to extract
metabolic information from gene expression profiles. In the
reporter metabolites approach [28] the local connectivity of a
metabolite in the bi-partite, substance/reaction graph is used to
identify a set of genes associated with each metabolite. Subse-
quently, for each of the metabolites, the distribution of the
microarray-derived signal of genes associated with the metabolite
is compared with the background distribution of the microarray-
derived signal for all genes, resulting in the identification of the
transcription regulation focal points of metabolism: network nodes
that are directly affected by clusters of differentially expressed
genes. In another approach, Shlomi [29] used Mixed Integer
Linear programming to minimize the discrepancy between the
internal metabolic flux distribution and the transcriptional profile
of genes encoding metabolic enzymes. Their approach identifies
flux distributions, which are consistent with the stoichiometric
constraints of the genome scale metabolic reaction network and at
the same time maximize the number of active metabolic fluxes
associated with up-regulated genes and the number of non-active
metabolic fluxes associated with down-regulated genes. Yet
another approach, E-flux, was recently developed and used to
examine M. tuberculosis microarray data in the context of the
genome scale metabolic reaction network, by constraining upper
bounds of metabolic reactions to values proportional to the
microarray signals of genes associated with these reactions [30]. In
this study we describe a novel approach, Differential Producibility
Analysis (DPA), which uses FBA to analyze microarray data in the
context of a genome scale metabolic network. The DPA method
differs from both the Shlomi method [29] and the e-flux method
[30] in avoiding assumptions concerning the relationship between
transcriptional signal and metabolic flux, depending instead (like
the reporter metabolite approach) only on network structure.
However, by application of FBA to associate metabolites with
genes, rather than graph theoretical approaches, the DPA method
is more global than the reporter metabolite approach [28] and
examines metabolites in the context of the entire metabolic
network rather than their local network environment. Each of
these approaches does however have its merits and data are not yet
available to identify the optimal means of predicting metabolism
from transcriptional profiles.
To test and validate the DPA approach we first applied it to a
transcriptional dataset obtained from a well-characterized system so
that the results of DPA could be compared with a known biological
response. We chose to analyze the transcriptional response of the
enteric bacterium E. coli to reduced oxygen availability and the
impact of the global regulator, FNR, on that response [25]. Having
validated the method we then applied DPA to analyze transcrip-
tomic data in the context of one of the available network models of
M. tuberculosis [18]. Our aim was to utilize differential transcript data
obtained for a number of in vitro and in vivo states to identify
characteristic global metabolic changes. We focused our studies on
attempting to define metabolic changes associated with the
adaptation of M. tuberculosis to the in vivo environment, as represented
by macrophage-grown M. tuberculosis and human sputum-derived M.
tuberculosis. We compared metabolic profiles for adaptation to the in
vivo environment to adaptation of M. tuberculosis to a range of in vitro
environments in an attempt to deconstruct the in vivo state into
components that can be studied in vitro.
Our analysis revealed a previously unrecognized feature of the
response of M. tuberculosis to the macrophage environment: a
down-regulation of genes influencing metabolites in central
metabolism. This was accompanied by up-regulation of many
genes that influence synthesis of cell wall components and
virulence factors, which had been identified in the original
transcriptome study [22]. The results suggest that a significant
feature of the response of the tubercle bacillus to the intracellular
environment is a channeling of resources towards remodeling of its
cell envelope, possibly in preparation for attack by host defenses
system. The study demonstrates that the DPA method can
successfully extract metabolic signals from transcriptomic data and
can be used to study global effects of gene regulatory changes. The
method may have general application for extracting metabolic
signals from other high-throughput ‘‘–omics’’ data.
Author Summary
Mycobacterium tuberculosis causes tuberculosis, leading to
millions of deaths each year. Treatment takes 6 months or
more, leading to lack of patient compliance and emer-
gence of drug resistance. The pathogen takes so long to
kill because it is able to enter a state of dormancy/latency/
persistence where it is insensitive to drugs. There is an
urgent unmet need to develop new antibiotics that target
dormant/persistent/latent organisms. Most antibiotics
target metabolic processes but it is difficult to examine
the metabolism of the pathogen directly inside the host or
host cells. It is of course possible to identify which genes
are active by transcriptomics but there are no established
and validated methods to use transcriptome data to
predict metabolism. We here describe the development of
such a method, called DPA. We validate the method with E.
coli data and then use DPA to predict the metabolism of
the TB pathogen growing inside host cells and from TB
sputum samples. DPA demonstrates that the TB bacillus
remodels its cells in response to the host environment,
possibly to increase the pathogen’s defenses against the
host immune system. Discovering the metabolic details of
this remodeling may identify vulnerable metabolic reac-
tions that may be targeted with new TB drugs.
DPA of the TB Bacillus
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Differential Producibility Analysis (DPA)
The aim of DPA is to identify those metabolites that are likely to
be most affected by a system-wide change in gene transcription.
Essentially DPA links up- or down-regulated genes with metab-
olites, using FBA essentiality, rather that more traditional pathway
identification tools (such as KEGG) or network analysis. Because a
large number of genes in multiple pathways of metabolism can be
essential to produce any particular metabolite, DPA captures a
more system-wide association between genes and metabolites than
are captured by any simple pathway approach. Figure 1 illustrates
the principle of the method for a toy example metabolic network
consisting of four metabolites and four genes. To perform DPA we
first utilized a FBA-based metabolite producibility plot [31] to
identify, at a system-level, the sets of genes that participate in the
production of each metabolite (Figure 1, step 1). Subsequently, for
each of the metabolites, we calculated a metabolite signal, defined
as the median microarray-derived data signal for those genes that
affect its production (Figure 1, step 2). Therefore, for each
microarray dataset, representing the experimental condition of
interest, we generated a vector of metabolite signals. To avoid
negation of gene expression signals for metabolites which were
associated with different sets of up- and down-regulated genes, the
analysis was performed separately for up and down-regulated
genes. Each metabolite in the network was then ranked according
to the average intensity of microarray signal associated with genes
that affect its production (Figure 1, step 3) using the non-
parametric Rank Products Analysis [32], which has been shown to
be the method of choice for meta-analysis of microarray datasets
derived by different research groups on different experimental
platforms. The detailed steps are described in the Methodology
section. The resulting ranked lists of metabolites that were
identified by DPA to be most affected by the transcriptional
response (we term these the affected metabolites) for all the conditions
were then subjected to cluster analysis to identify similar
experimental conditions that result in similar changes in global
metabolic state and to identify metabolites that have common
metabolite signal profiles across these experimental conditions
examined.
DPA analysis of E. coli microarray datasets
To investigate the utility of DPA for extracting metabolic signals
from transcription data we performed an analysis of microarray
data obtained from an experiment which aimed to identify the
transcriptional response of the enteric bacterium E. coli to reduced
oxygen availability and the impact of the global regulator, FNR,
on that response [25]. E. coli is a facultative anaerobe that can
survive and replicate in both aerobic and anaerobic environments.
Although preferentially utilizing aerobic respiration, the organism
is able to respond to reduced oxygen availability by shifting its
metabolic pathway utilization to mixed acid fermentation and
anaerobic respiration. The two-component global regulator, FNR,
is known to be involved in regulating the shift between aerobic and
anaerobic metabolism. FNR is a CAP (catabolite activator protein)
homologue that contains an oxygen labile iron-sulfur centre,
which acts as the oxygen sensor, and was known to regulate over
70 different genes. The aim of the target study was to identify
additional genes that are differentially expressed in response to
oxygen availability and discover which global changes were
mediated by FNR. The study was designed to measure the
transcriptomic profile of wild type (strain MC4100) E. coli grown
under aerobic (+O2) and anaerobic (2O2) conditions and also
FNR- strain (MC4100 Dfnr-2)o fE. coli grown only under
anaerobic conditions in order to identify the FNR response, Note
that the original paper classified genes into eight different
regulatory patterns (I to VIII) depending on whether gene
expression was higher, lower or unchanged in response to oxygen
and whether or not the response was FNR-dependent.
We performed DPA analysis of the two paired conditions: +O2/
2O2 and (2O2)+FNR/2FNR in the context of a genome-scale
metabolic model of E. coli [33]. We obtained four lists: Table S1a,
metabolites identified as associated with down-regulated genes on
exposure of wild-type E. coli to anaerobic conditions (correspond-
ing to regulatory patterns II, IV, V of [25]), Table S1b,
metabolites associated with up-regulated genes in the wild-type
in response to anaerobic growth (regulatory patterns I, III, VII),
Table S1c, metabolites associated with increased gene expression
in the FNR- strain grown under anaerobic conditions (regulatory
patterns I, V, VI), and Table S1d, metabolites associated with
decreased gene expression in the FNR-strain grown under
anaerobic conditions (regulatory patterns II, VII, VIII). These
lists are presented in Supplementary Tables S1a–d with brief
annotations of the most-significantly associated metabolites
indicating predominant metabolic pathways associated with each
metabolite. We compared DPA analysis with gene identification
and ontology analysis, as performed in the original published text
[25].
Metabolites identified by DPA to be associated with
down-regulated genes on exposure of wild-type E. coli to
anaerobic conditions (and thereby up-regulated during
aerobic growth)
The most notable characteristic of this metabolite list (Table
S1a) was the inclusion of many sugars (e.g. glucose and fructose)
and carbohydrates (e.g. glycogen) as well as intermediates (e.g.
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate)
that are metabolized predominantly aerobically via glycolysis
and the TCA cycle (e.g. fumarate). The microarray analysis
similarly identified genes involved in sugar metabolism (e.g. three
genes of the manXYZ operon and ptsG glucose phosphotransferase
system II) and the TCA cycle (e.g. genes encoding several
components of pyruvate dehydrogenase and alphaketogluterate
dehydrogenase) as being down-regulated during the shift to
anaerobic growth. Metabolic signals that were additionally
identified by DPA include iron (an essential cofactor of
cytochrome oxidase, whose genes were found to be repressed
during anerobic growth) and several metabolites involved in the
pentose phosphate cycle and propionate metabolism (e.g. the
methylcitrate cycle) as well as several metabolites involved in
lipopolysaccharide synthesis.
Metabolites identified by DPA to be associated with
up-regulated genes on exposure of wild-type E. coli to
anaerobic conditions
Under anoxic conditions, the active form of FNR exists as a
dimer with each monomer bound to an iron-sulfur cluster. The
sulfur within the cluster is donated by cysteine (through the action
of cysteine desulfurase) but glutathione is required to maintain the
complex in the reduced state [34]. It is thereby notable that both
cysteine and glutathione are identified by DPA amongst the
metabolites associated with the most up-regulated genes during
anaerobic growth (Table S1b); a response that was not detected in
the analysis of microarray signals. Hydrogen sulfide, both a
substrate of cysteine synthase and product of anaerobic respira-
tion, was also identified in this group. Consistent with the
microarray signal was the DPA identification of chloride as a
DPA of the TB Bacillus
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growth (three genes encoding a homologue of the mammalian
yadQ chloride channel were identified as up-regulated [25]). More
puzzling was the DPA identification of many metabolites involved
in peptidoglycan and glycerolipid synthesis. A few genes involved
in lipid synthesis, such as acetyl-coA transferase, were identified in
the microarray signal and a novel anaerobic b-oxidation pathway
has recently been identified to be active during anaerobic growth
of E. coli [35].
Metabolites associated with increased genes expression
in the FNR- strain grown under anaerobic conditions
(and thereby repressed by FNR in the wild-type)
Many of the metabolites identified in this group (Table S1c)
were also those identified by DPA ((i) above)) as being associated
with down-regulated genes on exposure of wild-type E. coli to
anaerobic conditions (and thereby up-regulated during aerobic
growth), consistent with the involvement of FNR in repressing
aerobic pathways.
Metabolites associated with decreased gene expression
in the FNR-strain grown under anaerobic conditions (and
thereby induced by FNR during anaerobic growth in the
wild-type)
The most notable characteristic of this list (Table S1d) was the
inclusion of several fermentation products including ethanol,
formate and acetaldehyde, consistent with a metabolic shift of E.
coli towards mixed acid fermentation under anaerobic conditions.
This signal was detected in the microarray analysis (e.g. both
formate and acetaldehyde dehydrogenase genes demonstrated
FNR-dependent induction in anaerobic growth). Also notable is
cobalamin, cofactor of the B12-dependent nucleotide reductase.
This signal was not identified in the original microarray study but
transcription of the nrdDG operon, which encodes this class III
nucleotide reductase, has since been shown to be strongly induced
by anaerobiosis in a FNR-dependent manner [36].
DPA analysis Of M. tuberculosis microarray datasets
Our principal aim was to gain insight into the in vivo metabolic
state of M. tuberculosis by comparison with growth in various in vitro
conditions (Table 1). We therefore performed DPA analysis of
microarray datasets in the context of the GSMT-TB metabolic
network of M. tuberculosis [18]. The first microarray dataset we
examined was taken from a study of M. tuberculosis replicating in
mouse macrophage [22]. The second model of the in vivo state was
a study on M. tuberculosis cells isolated from human sputum of
patients with TB [37]. The in vitro datasets we examined were from
a number of studies that performed microarray analysis of M.
tuberculosis growing on different substrates (succinate, palmitate), or
exposed to various toxic conditions (treatment with hydrogen
peroxide, low pH, UV radiation), or growth-limited in conditions
that are thought to mimic aspects of growth limitation in vivo
(NRP1 cells in the microaerobic ‘Wayne model’ of dormancy [38],
slow growth in the carbon-limited chemostat [39]). Note that this
is an in vitro model of dormancy/persistence and its relationship to
the asymptomatic and un-infectious state (often known as latency
but sometimes also referred to as dormancy or persistence) that is
encountered in vivo remains unclear [4]. DPA analysis of all
datasets is shown in the supporting information (Figure S1). The
source of each dataset is detailed in Table 1. The mouse
macrophage study examined M. tuberculosis grown in macrophages
that were either naı ¨ve or activated, wild-type or Nos1 mutants, at
various time-points. The experiments utilized two different
microarray formats. DPA was performed on each dataset. As
can be seen by (Figure S1), the DPA results, most of the mouse
macrophage experiments clustered closely together so for most
subsequent studies, the result of only one typical experiment (48 hr
infection, activated macrophages, amplicon microarray probes) is
discussed further. One-class Rank Products analysis was per-
formed (see Materials and Methods) to identify the top 100
metabolites predicted by DPA to be associated with up-regulated
genes and down-regulated genes (Supporting information, Table
S2) for each dataset.
The metabolic response associated with adaptation of M.
tuberculosis to growth in macrophages
Each of the top 100 metabolites associated by DPA with either
up- or down-regulated genes in the macrophage was classified into
broad areas of metabolism (e.g. nucleotide or lipid biosynthesis)
based on the pathway(s) that involved this metabolite in the
GSMT-TB model [18]. The full list of metabolite assignments can
be seen in Table S5. A pie chart was then used to compare the
metabolic processes most affected by up (Figure 2A) or down-
regulated (Figure 2B) M. tuberculosis genes when it adapts to the
mouse macrophage. As can be seen, there are large differences.
The most striking are: (i) metabolites involved in phospholipid
synthesis (principally phosphatidylinositol mannoside (PIM)),
mycolic acid synthesis, cell wall virulence factors (phenolphthio-
cerol dimycocerosate (PDIM), phenolic glycolipid (PGL), acyltre-
halose, mannosyl beta-1-phosphodolichol (MPD)) are mostly
associated with up-regulation in the macrophage; (ii) metabolites
associated with various central metabolism pathways were mostly
associated with down-regulation in the macrophage. This was
particularly apparent for metabolites involved in amino acid
metabolism that comprised 25% of the top 100 metabolites in the
Table 1. Abbreviations and source of M. tuberculosis
transcriptome data used in this study.
No Abbreviation Experiment Reference
1 Macrophage Activated (48 hr) macrophage [22]
2 Peroxide.1 H2O2 treatment [22]
3 Palmitate.1 PA treatment [22]
4 Peroxide.2 H2O2 treatment [58]
5 Azide NaN3 treatment [58]
6 NRP1exp NRP-1 (oxygen-limited) [58]
7 Palmitate.2 Growth on palmitate [58]
8 Ph4.8 pH 4.8 (acidic) treatment [58]
9 Succinate Growth on succinate [58]
10 UV Growth under UV radiation [58]
11 Chemostat TB growth under chemostat [44]
12 Sputum Sputum sample analysis
from TB patients
[37]
doi:10.1371/journal.pcbi.1002060.t001
Figure 1. Schematics of DPA illustrated through analysis of a toy metabolic network consisting of 4 metabolites (M1–M4) and 4
genes (g1–g4).
doi:10.1371/journal.pcbi.1002060.g001
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regulated. Other central metabolic themes that were mostly
associated with down-regulation in the macrophage were TCA
cycle metabolites, sugar metabolism, pyruvate metabolism (5%
compared to zero), cofactors (13% compared to 5%, the cofactors
involved were mostly involved in biotin, thiamine and F420
synthesis), nucleotide synthesis (4% compared to 0%) and heme
synthesis (9% compared to 0%). Also noteworthy, although the
numbers are small, is the observation that several metabolites
involved in anaerobic respiration (e.g. nitric oxide and molybde-
Figure 2. Pi chart illustrating the role of M. tuberculosis metabolites in macrophages. Pi chart illustrating the role of metabolites associated
by DPA with up-regulated (A) or down-regulated (B) genes in the mouse macrophage.
doi:10.1371/journal.pcbi.1002060.g002
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with down-regulated genes.
The metabolic response of M. tuberculosis isolated from
human sputum
To identify those metabolites that were most affected by the
transcriptional response of M. tuberculosis to the human sputum
environment a similar analysis to that documented above was
performed. The highest ranked metabolites associated with up-
and down-regulated genes in M. tuberculosis isolated from human
sputum (Supporting information, Table S2) were, perhaps
surprisingly, not particularly closely related to metabolites
associated with adaptation to the macrophage environment.
Metabolites associated with up-regulated genes were associated
with many cell wall components and virulence factors, such as
metabolites involved in peptidoglycan synthesis, synthesis of the
sulfolipid virulence factor SL-1 [40] (which was not up-regulated
in mouse macrophages), synthesis of arabinogalactan [41],
synthesis of phenolphthiocerol dimycocerosate (PDIM) [42],
synthesis of phosphatidylinositol mannoside (PIM) [43] and de
novo biosynthesis of nucleotides (e.g. deoxyuridine-diphosphate,
DUDP and deoxycytidine monophosphate, DCMP). Metabolites
associated with down-regulated genes in the sputum-derived cells
included several metabolites involved in amino acid synthesis but
also synthesis of several cofactors such as molybdenum and
coenzyme A (e.g. L-pantoate, PANT). Oxygen was also identified
as associated with down-regulated genes indicating perhaps a
down-regulation of genes involved in aerobic respiration.
The metabolic response of M. tuberculosis to various in
vitro conditions
The lists of top-ranking metabolites associated by DPA with
each in vitro condition (Supporting information, Table S2) showed
many interesting features. For instance, exposure to pH 4.8 was
associated with up-regulation metabolites such as 2-C-methyl-D-
erythritol-2,4-cyclodiphosphate (MDECPP) involved in polypre-
noid synthesis and metabolites involved in arabinogalactan
synthesis, but down-regulation genes were associated with
metabolites (such as 3-dehydroquinate, DQT) involved in
aromatic amino acid synthesis. Genes that were up-regulated on
exposure to hydrogen peroxide were associated with metabolites
involved in synthesis of the secreted siderophore mycobactin and
cobalamin synthesis but metabolites associated with down-
regulated genes were involved in peptidoglycan, nucleotide and
amino acid. Genes that were upregulated by slow growth of M.
tuberculosis in the chemostat were associated with metabolites such
as 2-methyl citrate and a-ketoglutarate, involved in the methyl
citrate cycle and TCA cycle respectively, together with several
metabolites involved in cobalamin synthesis (e.g. hydrogenobyr-
inate), biotin synthesis (e.g. 8-amino-7-oxononanoate), heme
synthesis (e.g. protoporphyrin-IX) and glutamate synthesis (e.g.
N-acetyl-L-glutamate). Genes that were up-regulated in the
Wayne model of dormancy NRP1 state [38] were associated with
many mycolic acid synthesis intermediates.
Comparison between datasets: deconstructing the
macrophage response
To gain insight into the metabolic overlap between the
macrophage-grown M. tuberculosis and various in vitro model
systems, we performed hierarchical cluster analysis of the resulting
ranked metabolite lists for all the experimental conditions followed
by identification of common metabolites in various experimental
conditions using Venn diagrams. First, metabolite signals (median
gene expression value for each metabolite) were ranked for each
experimental datasets. The experiments were then subjected to
hierarchical clustering using Pearson’s correlation coefficient of
metabolite signal ranks as a similarity measure. The trees reflecting
the degree of correlation between metabolite ranking order in each
experiment are shown on Figures 3a and 3b. Statistically
significant tree nodes, conserved in over 90% of bootstrap
replicates were identified as clusters. The analysis of metabolites
affected by up-regulated genes (Figure 3a) groups the NRP1
Wayne model of dormancy experiment [38], the slow-growth
chemostat model [18] and the macrophage derived M. tuberculosis
into a cluster separated from the remaining part of the tree at the
node conserved in 92% of bootstrap replicates. The close match
between the macrophage experiment and the slow growth in the
chemostat experiment suggests that M. tuberculosis is similarly
growth restricted in the macrophage environment. Slow growth is
also a component of the NRP1 cells, which may account for the
inclusion of this experiment into the same cluster. The cluster
analysis of metabolites associated with down-regulated genes
reveals a statistically significant cluster of four conditions
containing NRP1 cells, sputum, the slow-growth chemostat model
and in vitro acid stress. It is interesting to note that for metabolites
associated with both up and down-regulated genes the in vivo
model conditions (human sputum and mouse macrophage derived
M. tuberculosis) do not cluster together suggesting that different
metabolic pathways are activated in M. tuberculosis residing in
mouse macrophages compared to human sputum.
To identify specific metabolites responsible for the observed
level of clustering, we used Venn diagrams to compare the 100 top
ranked metabolites associated with up- and down-regulated genes
for each condition. The Venn diagram analysis, presented in
Figure 4, was performed in groups of three conditions that were
compared with each other and the M. tuberculosis macrophage
experiment (except for the last comparison which was with only
two conditions compared to the macrophage experiment). Each
experimental condition was associated with metabolites unique to
that condition and metabolites that were shared associated with a
range of conditions, as detailed in Supplementary Tables (Tables
S3 and S4 for metabolites associated with up- and down-regulated
genes respectively). Several interesting features of the analysis are
apparent. Firstly, metabolites associated with up-regulated genes
from macrophage-grown M. tuberculosis (Table S3) contained only
one metabolite unique to the macrophage (a mycolic acid
intermediate). No unique metabolites were associated with
down-regulated genes in the mouse macrophage (Table S4).
Many metabolites could be identified that were shared between
the macrophage experiment and other experiments. Some were
shared with very few other conditions whereas others were found
in several in vitro experiments. For example, metabolites involved
in synthesis of the virulence-associated phosphatidylinositol
mannoside (PIM) cell wall phospholipid were associated with up-
regulated genes in the macrophage and growth on palmitate
(palmitate.1. Note that the analysis includes two pairs of conditions
– peroxide and palmitate growth – that were commonly examined
in the two different studies. Perhaps surprisingly, the metabolite
signal was not very similar for these paired conditions. This
probably reflects differences in the way the experiments were
performed in the different laboratories). Metabolites involved in
synthesis of the virulence determinant, phenolphthiocerol dimy-
cocerosate (PDIM), were associated with up-regulated genes in the
macrophage but also the in vitro conditions NRP1, growth on
palmitate (palmitate.2) and exposure to either pH 4.8 or sodium
azide. Metabolites shared between up-regulated genes in both M.
tuberculosis grown in macrophages and M. tuberculosis isolated from
DPA of the TB Bacillus
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glyceraldehyde-3-phosphate and monoacylglycerol, both involved
in triglyceride synthesis. Metabolites involved in cholesterol
metabolism were shared between macrophage-grown M. tubercu-
losis and growth on palmitate, which is consistent with cholesterol
and palmitate requiring similar lipid oxidation pathways for
catabolism. More surprisingly, metabolites involved in cholesterol
metabolism were also associated up up-regulated genes during
slow growth in the chemostat and NRP1 in the Wayne model of
dormancy, despite the fact that cholesterol was not available in
either condition. The result may indicate that pathways involved
in cholesterol metabolism may be activated in M. tuberculosis by
non-lipid signals, such as nutrient starvation.
As already mentioned, there were no unique metabolites
associated down-regulated genes in the macrophage (Table S4).
Most of the metabolites common to the macrophage and in vitro
conditions were involved in central metabolism, amino acid
synthesis/degradation, and respiration. However, some specific
responses were also apparent. Metabolites (e.g. protoporphyrin-
IX) involved in heme synthesis were commonly associated with
down-regulated genes in macrophages, growth on succinate, and
exposure to pH 4.8. Pentose phosphate pathway metabolites, such
as ribose and deoxyribose-5-phosphate (DR5P) were commonly
associated with down-regulated genes in the macrophage, NRP1
and slow growth in the chemostat, as were several metabolites
involved in amino acid synthesis, such as 3-hydroxy-isobutyrate
(HIBUT) and 3-phospho-hydroxypyruvate (PHP). Metabolites
involved in biotin synthesis were associated with down-regulated
genes in macrophages and growth on palmitate (palmitate.1).
Discussion
Several different methods are currently available for extracting
metabolic information from transcriptome data. The method that
has been used the longest is simply to infer metabolic changes from
the nature of genes that are up or down-regulated. However, one
of the key insights of systems biology is that control of any system
tends to be distributed so the activity of any single gene does not
necessarily reflect the state of the system as a whole. For this
reason, recent attempts to extract metabolic information from
transcriptome data have utilized genome-scale metabolic models
as a tool to extract system-level metabolic signals. DPA is such a
system-based method that analyzes transcriptome data on a
framework of gene-metabolite relationships established by FBA. It
is a global method that examines the contribution of every gene in
the network to the production of every metabolite in the network.
There are several aspects of DPA that merit consideration. First,
unlike the method of Shlomi [29] and the E-flux method [30] it
makes no attempt to predict actual fluxes. We believe that such an
approach is realistic, given the uncertainties of the mapping from
the transcriptome through the proteome to the metabolome; and
we note that flux predictions of the above methods had not yet
been checked against experimentally-derived fluxes, such as those
obtained by 13C-Metabolic Flux Analysis. DPA can be compared
to the reporter metabolite approach [28], but, rather than relying
on local connectivity, DPA utilises FBA to establish genome-scale
linkages between metabolites and genes and may thereby detect
the influence of distant gene expression events on each metabolic
step. To put it another way, whereas the reporter metabolite
method ‘is basically a test for the null hypothesis, ‘‘neighbour
enzymes required for synthesis of a metabolite in the metabolic
graph show the observed normalized transcriptional response by
chance’’’ [28]; DPA is a test of the null hypothesis, ‘‘all enzymes
required for synthesis of a metabolite in the metabolic graph show
the observed normalized transcriptional response by chance.’’
Secondly, DPA separately analyses metabolites associated into
both up- and down-regulated genes. This does generate some
anomalies, such as the occasional presence of the same metabolite
in both sets of lists (a metabolite associated with both up- and
down-regulated genes – but usually with very different rank order),
but its advantage is that it avoids cancellation of signal from
metabolites associated with both up- and down-regulated genes.
Secondly, we found that a few metabolites were not examined by
DPA. This was found to be due to redundancy in synthesis
pathways, rendering some metabolites (often in central metabolic
pathways) essentially invisible to differential producibility analysis
since no genes were essential for their production. Nevertheless,
despite these potential drawbacks, DPA proved to a powerful tool
for extracting metabolic signals from transcriptome data.
We chose to test DPA using an established dataset obtained
from a well-characterized system: the response of E. coli to
anaerobic growth and the role of the FNR global regulator [25] in
that response. The value of DPA was clearly demonstrated by its
consistency with gene ontology identification in the original study
of a metabolic shift from aerobic sugar utilization via glycolysis,
pentose phosphate pathway and TCA cycle towards anaerobic
utilization of fermentation pathways [25]. DPA also identified
repression of the aerobic pathways for sugar utilization as a major
target for the action of FNR. However, DPA was able to identify
additional metabolic signals in the transcriptome data that was not
identified by gene ontology analysis. For instance, DPA identified
components of cysteine and glutathione metabolism as being
activated during anaerobic growth which is consistent role of these
metabolites in activation of FNR under anaerobic conditions [34].
Also, cobalamin synthesis was highlighted by DPA as being FNR-
dependent and although this had not identified in the original
study, the role of FNR in cobalamin synthesis, has since been
demonstrated [36].
With the value of DPA demonstrated in a well-characterized
system, we then used the technique to investigate the transcrip-
tional response of M. tuberculosis to environmental stresses and
replication in the macrophage. Firstly, we were able to identify
previously recognized features in several of the datasets we
examined, confirming the utility of the method. For instance,
Schnappinger [22] identified genes (such as UmaA) involved in
mycolic acid synthesis that were up-regulated in M. tuberculosis
grown inside macrophages, and we were also able to identify
several intermediates in mycolic acid synthesis that were associated
with up-regulated genes in the same dataset. Similarly, Beste [44]
identified protein synthesis and modification as being down-
regulated in slow-growing M. tuberculosis in the chemostat, and
metabolites associated with amino acid metabolism were found to
be associated with down-regulated genes in the same dataset (a
response shared with macrophage and NRP1-derived cells) by
DPA analysis. DPA also revealed features of exposure of M.
tuberculosis to in vitro environments that were consistent with existing
knowledge. For instance, genes that were found to be up-regulated
in both macrophage-grown M. tuberculosis and M. tuberculosis
Figure 3. Clustering of M. tuberculosis gene expression datasets. Clustering of gene expression datasets based on DPA of metabolites
associated with up-regulated genes, A) and down-regulated genes, B). Red numbers indicate the Approximately Unbiased (au) multiscale bootstrap
based p-value for dendrogram. We used 90% confidence to identify significant clusters (with Red bounding boxes).
doi:10.1371/journal.pcbi.1002060.g003
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as mycobactin, involved in iron uptake. Iron is a cofactor of the
enzyme catalase that would be expected to be up-regulated on
exposure to peroxide. Increased catalase synthesis would require
increased iron uptake and therefore increased synthesis of the
siderophore mycobactin. That this response is common between
mouse macrophage-grown M. tuberculosis and peroxide-treated M.
tuberculosis is consistent with data indicating that M. tuberculosis is
Figure 4. Venn diagrams comparing M. tuberculosis metabolites associated by DPA with different experimental conditions. Venn
diagrams comparing the top 100 significant metabolites associated with up-regulated (A) and down regulated (B) genes (refer to Supplementary
Information Table S2 for the detailed metabolite list for each experimental condition).
doi:10.1371/journal.pcbi.1002060.g004
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thereby allows the response of M. tuberculosis to the host
environment to be deconstructed into components that can be
studies in vitro.
One of the most striking features of DPA analysis of the
macrophage data was the number of metabolites associated with
up-regulated genes that are involved in the synthesis of cell
envelope lipid components including mycolic acids and envelope-
associated several virulence factors such as phosphoinositol
mannosides and phenolic glycolipid are associated with upregu-
lated genes when M. tuberculosis is growing in macrophage
metabolites. The most likely explanation is that exposure to the
macrophage environment stimulates M. tuberculosis to remodel its
outer surface, as was suggested from analysis of the microarray
data [22], possibly in preparation for attack by host defenses. A
distinctive feature of the TB bacillus is its high lipid content
(approximately 40% of its cell mass) and the large number of genes
(more than 250) involved in lipid and polyketide synthesis and
degradation in the TB genome (Cole et al., 1998). Several
antituberculous drugs, such as isoniazid and pyrazinamide, are
known to target lipid biosynthesis. It is widely believed that a key
component of the adaptation of the TB bacillus to the intracellular
environment is a switch to consuming host lipids [5] including
activation of genes, such as the isocitrate lyase gene, involved in
the degradation of lipids. However, our analysis indicates that lipid
metabolism in M. tuberculosis during infection is also likely to be
directed towards lipid biosynthesis involved in remodelling the cell
surface. Unraveling the molecular details of this remodeling may
provide novel drug targets.
However, in addition to areas of metabolism that were
highlighted in the original macrophage transcriptome study,
DPA identified several other components of the adaptation of
M. tuberculosis to the macrophage that had not been identified in
the original analysis, such as cofactor synthesis. Genes involved in
the synthesis of the cofactors cobalamin and F420 tended to be up-
regulated in the macrophage whereas genes associated with
synthesis of biotin tended to be down-regulated. Coenzyme F420
is involved in redox reactions such as the F420-dependent glucose-
6-phosphate dehydrogenase and is required for activation of the
experimental antituberculosis drug PA-824 by M. tuberculosis [46];
whereas cobalamin is involved in several biosynthetic reactions
including nucleotide and fatty acid synthesis and has recently been
identified as essential for operation of the methylmalonyl pathway
of propionate utilization in M. tuberculosis [47]. Both of these could
potentially provide new targets for antituberculous drugs. Biotin is
involved in many biosynthetic reactions, most notably fatty acid
synthesis, where it is a cofactor for the acetyl-CoA carboxylase
carboxytransferase function; so it was surprising to find that many
genes involved in its synthesis are down-regulated in the
macrophage. The result may indicate that the proposed
remodeling of the cell envelope indicated by our analysis takes
place without de novo synthesis of fatty acids, possibly by utilizing
host-derived lipids as substrates; or the result could indicate
increased lipid synthesis is mediated by post-transcriptional control
not captured in this analysis. Metabolites involved in the synthesis
of several aromatic amino acids were also found to be associated
with up-regulated genes by DPA analysis. The results are
consistent with the finding that many amino acid auxotroph of
M. tuberculosis are attenuated in vivo indicating that the pathogen is
unable to obtain these amino acids from the host [48] [49].
Concomitant with the DPA signal indicating increased cell wall
lipid synthesis, the analysis indicated that metabolites involved in
central metabolism were generally associated with down-regulated
genes when M. tuberculosis enters the macrophage. This down-
regulation of many (but not all) central metabolic pathways was
also found for in vitro perturbations such as slow growth in the
chemostat and exposure to hydrogen peroxide and is consistent
with our previous study indicating that down-regulation of growth
rate is likely to be a key early component of the adaptation of M.
tuberculosis to the macrophage environment [18]. This finding is
perhaps puzzling given the above indications of increased
biosynthetic metabolism towards lipid and amino acid synthesis.
Once again, the explanation may be that the early adaptation of
the tubercle bacillus to the macrophage environment is achieved
mostly by a redirection of metabolism using preexisting metabo-
lites, rather than de novo synthesis of the those metabolites via the
metabolic precursors generated from central metabolism: a
remodeling rather than a renewal of the cell.
DPA of sputum-derived M. tuberculosis similarly revealed an up-
regulation of metabolites involved in cell wall and virulence factor
synthesis, with some similarities but also clear differences from
analysis of the macrophage data. Metabolites associated with up-
regulated genes from M. tuberculosis cells derived from human
sputum (but not mouse macrophages) were involved in synthesis of
the sulfolipid virulence factor SL-1 and also peptidoglycan
synthesis; whereas the macrophage derived cells (but not
sputum-derived cells) were associated with phenolic glycolipid
(PGL) and acyltrehalose synthesis. The results indicate that
mycobacteria isolated from human sputum have quite a different
metabolic signature from mycobacteria grown in mouse macro-
phages. DPA of sputum down-regulated genes also identified
several metabolites involved in molybdenum synthesis, a cofactor
of nitrate reductase, narX, involved in anaerobic respiration. It is
possible that this response indicates a switch away from anaerobic
respiration in sputum-derived M. tuberculosis cells.
It is also notable that none of the in vitro conditions examined
generated the same DPA metabolic profile as in vivo-grown M.
tuberculosis cells indicating that there are aspects of in vivo
metabolism of M. tuberculosis that are not captured by any single
in vitro model. The analysis may thereby shed light differences
between drug sensitivity in vivo and in vitro. For instance, isoniazid is
widely used to prevent progression from latent to active disease
[50] but has no effect on M. tuberculosis in the Wayne model of
dormancy [51]. DPA provides insight into the underlying
similarities and differences between the metabolic state of M.
tuberculosis in vitro and in vivo that may provide clues to development
of novel in vitro systems that more closely simulate the
environmental conditions experienced by M. tuberculosis in vivo.
In summary, the method described here provides a novel way
of using a metabolic network to analyze gene expression data.
The method can be automatically applied to data to provide
novel hypotheses concerning hidden metabolic signals. Poten-
tially, DPA can be applied to other high-throughput data sets
(e.g. proteomics) to integrate more information and capture
other levels of control (e.g. protein degradation as opposed to
mRNA degradation). Here we have demonstrated the utility of
the method by using DPA to analyze the gene expression
response of M. tuberculosis to the macrophage environment. The
data suggests that the tubercle bacillus responds to the
macrophage environment by shutting down central metabolic
pathways but increasing activity in lipid biosynthetic pathways
possibly in an effort to remodel its surface in anticipation of
attack by host defenses. The analysis also demonstrated that the
response of M. tuberculosis to the intracellular environment could
be deconstructed into components that can be studied in vitro.
The DPA method may be used to extract metabolic information
from any microarray dataset where the appropriate metabolic
model is available.
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The aim of DPA is to identify a set of metabolites whose
production/consumption (producibility) is expected to be different
between two conditions on the basis of gene expression differences.
The method utilizes has some features in common with another
method, Analysis of Differentially Affected Metabolites (ADAM) that
will be described elsewhere (E. Laing et al., paper in preparation). To
perform DPA analysis we first utilize a FBA-based metabolite
producibility plot to identify, at a system-level, the sets of genes that
participate in the production of each metabolite. This is essentially a
binary matrix that links genes with metabolites on the basis of
whether or not each gene is essential for production of each
metabolite. Subsequently, for each of the metabolites, we calculate a
metabolite signal, defined as the median microarray-derived data
signal for those genes that affect its production. Therefore, for each
microarray dataset, representing the experimental condition of
interest, we generate a vector of metabolite signals that we sometimes
refer to as the metabolite state. These data may then be subjected to
cluster analysis to identify experimental conditions that result in
similar changes in global metabolite state (the sum of all metabolites
in the cell) and metabolites that have common metabolite signal
profiles across the experimental conditions examined. To avoid
negation of gene expression signals for metabolites which were
associated with different sets of up- and down-regulated genes, the
analysis was performed separately for up and down-regulated genes.
Each metabolite in the network was then ranked according to the
average intensity of microarray signal associated with genes that affect
its production (Figure 1, step 3) using the non-parametric Rank
Products Analysis [32], which has been shown to be the method of
choice for meta-analysis of microarray datasets derived by different
research groups on different experimental platforms. Rank Product
Analysis has been shown to be robust against experimental noise and
performs well in comparison to other typical microarray analysis
strategies[52].TheworkflowofDPAanalysisisillustratedinFigure1;
below we describe in detail the individual steps.
Flux balance analysis
We used Flux Balance Analysis (FBA) to interrogate our genome
scale model of M. tuberculosis metabolism to obtain lists of genes
associated with the synthesis of metabolites in the network. FBA
has become a standard method for large-scale metabolic network
modeling and is discussed in detail in numerous articles [53–55].
In this work we calculate the maximal theoretical flux towards
each metabolite in the network. Following definition of the
metabolite producibility in [56] the row of the stoichiometric
matrix corresponding to the metabolite in question is used to
define the objective function. Note that exactly the same value of
metabolite producibility is obtained if a new reaction that
consumes the metabolite as its only substrate is introduced to
the model and the flux through this reaction is used as the
objective function. The GSMN-TB model provides Boolean
formulas describing association between genes and reactions.
These formulas are used to identify reactions, which require
activity of each gene. A detailed description of the FBA
calculations can be also found in our previous work, which
describes the development of the GSMN-TB model and accounts
for assumptions specific to this model such as ‘‘replenishing flux’’
used to model requirement for enzyme cofactors. All FBA
calculations were as described in [18].
Producibility plot
In the first step of DPA, for each metabolite, a set of genes that
are required for the reactions affecting the cellular level of the
metabolite is obtained. Our aim was to not only take into account
the genes participating in reactions synthesizing or consuming
each metabolite, but to also consider global effects i.e. the existence
of reactions anywhere in the network that affects the flux towards
that metabolite. For this analysis we utilized the producibility plot
method formulated by Imielinski [56], making each metabolite m
an objective function of a single Flux Balance Analysis optimiza-
tion and iterate the procedure over all metabolites in the network.
For the analysis of M. tuberculosis, to capture gene-metabolite
associations under a variety of conditions, the FBA was performed
separately with the substrates glucose, glycerol, acetate, propano-
ate and cholesterol and the resulting associations pooled. The
maximal theoretical flux towards metabolite m in a wild-type
model in which all genes are active was first calculated.
Subsequently, we calculate the maximal theoretical flux towards
metabolite m in the network in which each reaction in the model
annotated as catalyzed by product of gene g is inactivated, i.e. the
fluxes of all reactions, which involve g are constrained to 0. For
each pair m, g we then calculate a difference DFm,g=F m,g2Fm,wt,
between the maximal flux towards m in the gene g knockout model
(Fm,g) and the wild type model (Fm,wt). This results in a matrix P, in
which rows are indexed with metabolites, columns are indexed
with genes and which cells contain DFm,g values for all gene-
metabolite pairs. We represent P in binary form in which we assign
1 to all DFm,g values different from 0 (0.001 absolute value cut-off
is used) and assign 0 to the remaining cells in the matrix, where no
change is observed as the result of g inactivation. The binary form
of matrix P can be visualized as a dot-plot and is referred to as the
Producibility Plot. In the remaining part of this article we will also
refer to the maximal flux towards metabolite m as the producibility of
m.
The resulting metabolite producibility is a function of the
‘‘structural network’’ and reaction reversibility (and hence reaction
bounds), or simply, topology and physical constraints of the
network.
Calculation of metabolite signals from microarray data
In the second step of DPA we incorporate data from the
microarray datasets representing different experimental condi-
tions. The log2 ratios of treatment and reference sample signals as
calculated by authors of these datasets were used (no processing of
data was conducted); genes were classed as up-regulated if they
had positive log2 signal ratios and down-regulated if negative.
To analyse microarray data in the context of the GSMN-TB
model we define a ‘metabolite signal’ as the median log2
microarray signal ratio of genes influencing producibility of the
given metabolite. To calculate metabolite signals we first use the
producibility plot to identify for each metabolite m in the network
a set Sm of genes that affect its producibility. These genes are
identified from a set of non-zero elements in the rows of the binary
producibility plot corresponding to m. To integrate data from
array a, for each metabolite we calculate the median up-regulated
metabolite signal, Um,a , from all up-regulated genes in array a in
Sm. Similarly, all down-regulated genes in Sm were used to
calculate the metabolite signal of downregulated genes Dm,a.A sa
result, we obtain metabolite signal matrices U and D, where rows
are metabolites, columns arrays, and values are metabolite signals
due to the up and down regulated genes respectively. It is these
matrices upon which all subsequent clustering and Rank Products
analysis are based.
Cluster analysis
We performed hierarchical cluster analysis (HCL) to identify
groups of experimental conditions that induce similar metabolic
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we ranked all metabolite signal values in each column of the U and
D metabolite signal matrices, resulting in matrices Uranked and
Dranked. Thus the row for each metabolite m in Uranked and Dranked
contains the ranks of the metabolite signal of m across all
treatment/reference microarrays. Subsequently, the hierarchical
clustering was performed with the pvclust package of the R
environment, with Pearson correlation as a distance measure and
complete linkage [57]. The pvclust package was also used to
calculate statistical significance of clusters by the bootstrap method
[57] for assessing the uncertainty in hierarchical cluster analysis,
10,000 bootstrap replicates were generated. Tree nodes, which
were retained in 90% of the replicates, as calculated by the
Approximately Unbiased (au) multiscale bootstrap method [57],
were considered statistically significant.
Rank products analysis
The Rank Product analysis is a non-parametric statistical test,
which has been developed for identification of differentially
expressed genes in microarray data [32]. Briefly, the method
analyses a data table where rows represent cases (genes) and
columns represent repeated measurements. In the one-class case
the columns of the data table contain signal log ratios for the
comparison of two conditions. In a two class-case the columns are
assigned to two classes and the software calculates all pairwise
differences between the log signal ratios of columns belonging to
the two classes. In the next step the program ranks each column of
log-signal ratios and identifies cases (genes), which consistently
rank at top of the list in each repetition of the experiment. For
each case the product of ranks of this case in each of the replicates
is calculated. This obtained value is compared to the values
calculated in multiple randomized datasets (shuffling of case
names) to calculate P-values and corresponding Percentage of
False Discovery. Because the method is based on ranks it is robust
with respect to many assumptions, such as normality and is
particularly suitable to meta-analysis of datasets collected in
different laboratories and on different experimental platforms.
In our work we used Rank Products analysis to identify
differentially produced metabolites. The U and D matrices
described above were submitted to the RankProd function of the
Bioconductor package in the R environment. By using all
treatment/reference log2 ratios as input to one-class Rank
Products analysis (a method typically applied to two-colour direct
comparison microarray experiments) we feed all the replicates of
the experiments as a data column (if no replicate available then
treat every experimental condition as a ‘replicate’); for any
metabolite to be identified as being significantly different between
the ratio numerator and denominator there must be consistency
across experimental conditions. Thus, this analysis identifies
common features of E. coli and M. tuberculosis metabolic response
to different experimental conditions. To identify differences
between metabolite states between experimental conditions a two-
class Rank Products analysis of multiple treatment/reference ratios
for each condition was employed. The P-value and PFP
(probability of false prediction) value obtained from the output
of Rank Products analysis was used to determine the significance
of the metabolic response.
To check the robustness, we examined the DPA based rank
product analysis in M. tuberculosis and E. coli datasets.
Datasets and metabolic model
For E. coli DPA we used the iAF1260 genome scale metabolic
network [33]. All the FBA simulation of producibility plot for E.
coli were performed in pyFBA (Python based unpublished toolbox)
with the GLPK linear programming toolkit. The E. coli
transcriptome database that was analyzed was taken from a
microarray study of the E. coli growing in aerobic and anaerobic
conditions, both wild-type and an FNR- strain [25].
DPA was also applied to transcriptome data sets representing
the global gene expression program of the M. tuberculosis bacillus in
the macrophage environment, human sputum and a range of in
vitro environmental perturbations. These data were analyzed in the
context of the previously published GSMN-TB genome-scale
metabolic network [18]. Transcriptome data sets and the GSMN-
TB model are described below.
The gene expression data obtained from Schnappinger [22], is
from M. tuberculosis cells harvested at 4, 24 and 48 hours after
infection of macrophages. Each dataset contains the result of a
‘two-color’ microarray hybridization experiment with the refer-
ence condition in each case being bacteria grown to mid-log phase
in 7H9, a standard M. tuberculosis culture medium. We chose the
activated macrophage 48 hr after infection (referred to as
macrophage) data as a representative of the in vivo state of the
TB bacillus. The in vitro conditions from the same experimental
dataset included experiments where the TB bacillus was exposed
to 5 mM hydrogen peroxide for 40 minutes (peroxide.1) and cells
grown on palmitic acid as a carbon source (palmitate.1). Other in
vitro datasets were taken from a large study of M. tuberculosis
exposed to a variety of environments [58]. We chose the following
datasets: Growth on succinate (succinate), oxygen-limited NRP-1
cells which represent cells grown in the ‘Wayne model’ of M.
tuberculosis dormancy [38], starvation, pH 4.8, UV radiation,
NaN3 treatment (azide), hydrogen peroxide treatment (peroxide.2)
and growth on palmitate (palmitate.2). These in vitro conditions
were chosen to model aspects of the presumed in vivo environment
of the TB bacillus. The third dataset was taken from the study of
[37] of human sputum-derived M. tuberculosis samples. Finally, we
also analyzed a transcriptional dataset obtained from our own
studies that represents the response of M. bovis BCG to slow growth
in the chemostat with glycerol as a sole carbon source [44]. All of
the microarray datasets were converted to log2 fold change
(treatment/reference) ratios for ease of comparison. Table 1 shows
the abbreviations used for each experimental condition and the
data source.
The previously published genome scale metabolic network of M.
tuberculosis [18] was modeled using flux balance analysis, as
described. An updated GSMN-TB model can be obtained in the
tab delimited text or SBML format from the website http://
sysbio3.fhms.surrey.ac.uk/.
Supporting Information
Figure S1 DPA of all M. tuberculosis experimental datasets
displayed as a heat map with metabolite rank displayed as
intensity of color. DPA of up-regulated genes is shown on the left
in red and DPA of down-regulated genes is displayed on the right
in green colour. Clustering of experiments is indicated as a
dendrogram at the top of each heat map and clustering of
metabolites is shown on the left.
(TIFF)
Table S1 Metabolites associated with up- and down-regulated
genes in E. coli. Table S1a, metabolites identified as associated with
down-regulated genes on exposure of wild-type E. coli to anaerobic
conditions (corresponding to regulatory patterns II, IV, V of [25]),
Table S1b, metabolites associated with up-regulated genes in the
wild-type in response to anaerobic growth (regulatory patterns I,
III, VII), Table S1c, metabolites associated with increased gene
expression in the FNR- strain grown under anaerobic conditions
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associated with decreased gene expression in the FNR-strain
grown under anaerobic conditions (regulatory patterns II, VII,
VIII).
(XLS)
Table S2 Top 100 metabolites predicted by DPA and identified
by one-class Rank Products analysis (see Materials and Methods)
as associated with up-regulated and down-regulated M. tuberculosis
genes for each dataset.
(XLS)
Table S3 Metabolites that are shared between different
experimental conditions (Venn diagram, Figure 4) associated with
up-regulated M. tuberculosis genes.
(XLS)
Table S4 Metabolites that are shared between different
experimental conditions (Venn diagram, Figure 4) associated with
down-regulated M. tuberculosis genes.
(XLS)
Table S5 Metabolite assignments classified into broad areas of
metabolism based on the pathway(s) that involved each metabolite
in the GSMT-TB genome-scale metabolic network model.
(XLS)
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